Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to Existing Contact Lens Regimens
- Conditions
- Normal Contact Lens Wearers
- Interventions
- Device: Clear CareDevice: Multi-purpose disinfecting solutionDevice: Opti-Free RepleniSH
- Registration Number
- NCT01294917
- Lead Sponsor
- Abbott Medical Optics
- Brief Summary
Crossover clinical evaluation three contact lens care regimens used for one month with Acuvue Oasys lenses.
- Detailed Description
This is a three-arm crossover clinical evaluation of 40 subjects who will use each of three contact lens care regimens for one month with Acuvue Oasys lenses. The subjects will be randomized on the order of solutions used: Investigational MPS, ClearCare, and Opti-Free RepleniSH MPS.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Is at least 17 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Has had an ocular examination in the last two years;
- Is a current soft lens wearer using either two-week or monthly replacement lenses;
- Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction (either spectacles or contact lenses);
- Has normal binocular vision (no strabismus, no amblyopia);
- Has clear corneas and no active ocular disease;
- Has a distance contact lens prescription between +8.00 diopters (D) to -12.00 D and a successful fit with the study lenses;
- Has astigmatism less than or equal to -1.00 D;
- Agrees to wear the study lenses on a daily wear basis.
- Has any active ocular disease;
- Has any clinically significant lid, conjunctival, or corneal abnormalities that may affect a study outcome variable;
- Has undergone corneal refractive surgery;
- Has a systemic condition that may affect a study outcome variable;
- Is using any systemic or topical medications that may affect ocular health;
- Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
- Is pregnant or lactating;
- Is participating in any other clinical or research study that may affect a study outcome variable;
- Currently wears daily disposable lenses or extended wear lenses.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Clear Care Clear Care Peroxide-based lens care regimen. Investigational MPS Multi-purpose disinfecting solution AMO Investigational MPS. Opti-Free RepleniSH Opti-Free RepleniSH Multi-purpose disinfecting solution (Alcon).
- Primary Outcome Measures
Name Time Method Corneal Staining 4 weeks Corneal staining will be assessed with sodium fluorescein dye on the ocular surface. The cornea is split into 5 sections, each section is evaluated by staining type, depth, and extent is graded on a 0 to 100 scale with higher scores indicating more staining. The possible total range for the total score per eye is 0 to 50,000 (100x100x100=10,000 per section) with values higher than 1200 being clinically relevant.
- Secondary Outcome Measures
Name Time Method Subjective Lens Wearing Comfort 4 weeks This will be assessed by a questionnaire on patient-perceived lens comfort and any symptoms of discomfort on a 0 to 100 scale.
Dryness 4 weeks This will be assessed by the tear break-up time on the lens surface, measured in seconds.
Trial Locations
- Locations (1)
Centre for Contact Lens Research
🇨🇦Waterloo, Ontario, Canada